{
    "Trade/Device Name(s)": [
        "Multiple Analyte Urine Calibrators and Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K051088",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993755",
        "K983159"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "June 24, 2005",
    "Summary Letter Received Date": "April 28, 2005",
    "Submission Date": "April 26, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology calibrator",
        "Drug Mixture Control Materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzoylecgonine",
        "Methamphetamine",
        "Methadone",
        "Morphine",
        "Oxazepam",
        "Secobarbital",
        "Phencyclidine",
        "Propoxyphene"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Lin-Zhi International Multiple Analyte Urine Calibrators and Controls for enzyme immunoassay calibration and validation of drugs of abuse in human urine",
    "Indications for Use Summary": "Intended for in vitro diagnostic use for calibration and validation of enzyme immunoassays to detect methamphetamine, benzoylecgonine, opiate, benzodiazepines, barbiturates, methadone, phencyclidine, or propoxyphene in human urine",
    "fda_folder": "Toxicology"
}